Skip to main content
Erschienen in: Cellular Oncology 4/2018

01.03.2018 | Original Paper

Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis

verfasst von: Noemi Eiro, Lucía González, Anxo Martínez-Ordoñez, Belen Fernandez-Garcia, Luis O. González, Sandra Cid, Francisco Dominguez, Román Perez-Fernandez, Francisco J. Vizoso

Erschienen in: Cellular Oncology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

It has been reported that stromal cell features may affect the clinical outcome of breast cancer patients. Cancer associated fibroblasts (CAFs) represent one of the most abundant cell types within the breast cancer stroma. Here, we aimed to explore the influence of CAFs on breast cancer gene expression, as well as on invasion and angiogenesis.

Methods

qRT-PCR was used to evaluate the expression of several cancer progression related genes (S100A4, TGFβ, FGF2, FGF7, PDGFA, PDGFB, VEGFA, IL-6, IL-8, uPA, MMP2, MMP9, MMP11 and TIMP1) in the human breast cancer-derived cell lines MCF-7 and MDA-MB-231, before and after co-culture with CAFs. Stromal mononuclear inflammatory cell (MIC) MMP11 expression was used to stratify primary tumors. In addition, we assessed the in vitro effects of CAFs on both MDA-MB-231 breast cancer cell invasion and endothelial cell (HUVEC) tube formation.

Results

We found that the expression levels of most of the genes tested were significantly increased in both breast cancer-derived cell lines after co-culture with CAFs from either MMP11+ or MMP11- MIC tumors. IL-6 and IL-8 showed an increased expression in both cancer-derived cell lines after co-culture with CAFs from MMP11+ MIC tumors. We also found that the invasive and angiogenic capacities of, respectively, MDA-MB-231 and HUVEC cells were increased after co-culture with CAFs, especially those from MMP11+ MIC tumors.

Conclusions

Our data indicate that tumor-derived CAFs can induce up-regulation of genes involved in breast cancer progression. Our data additionally indicate that CAFs, especially those derived from MMP11+ MIC tumors, can promote breast cancer cell invasion and angiogenesis.
Literatur
1.
Zurück zum Zitat T. Marsh, K. Pietras, S.S. McAllister, Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070–1078 (2013)CrossRefPubMed T. Marsh, K. Pietras, S.S. McAllister, Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 1832, 1070–1078 (2013)CrossRefPubMed
2.
Zurück zum Zitat I. Kogan-Sakin, M. Cohen, N. Paland, S. Madar, H. Solomon, A. Molchadsky, R. Brosh, Y. Buganim, N. Goldfinger, H. Klocker, J.A. Schalken, V. Rotter, Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis 30, 698–705 (2009)CrossRefPubMed I. Kogan-Sakin, M. Cohen, N. Paland, S. Madar, H. Solomon, A. Molchadsky, R. Brosh, Y. Buganim, N. Goldfinger, H. Klocker, J.A. Schalken, V. Rotter, Prostate stromal cells produce CXCL-1, CXCL-2, CXCL-3 and IL-8 in response to epithelia-secreted IL-1. Carcinogenesis 30, 698–705 (2009)CrossRefPubMed
3.
Zurück zum Zitat M.P. Protti, L. De Monte, Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer. Oncoimmunology. 1, 89–91 (2012)CrossRefPubMedPubMedCentral M.P. Protti, L. De Monte, Cross-talk within the tumor microenvironment mediates Th2-type inflammation in pancreatic cancer. Oncoimmunology. 1, 89–91 (2012)CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat S. Koontongkaew, The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J. Cancer 4, 66–83 (2013)CrossRefPubMedPubMedCentral S. Koontongkaew, The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J. Cancer 4, 66–83 (2013)CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat S. Madar, I. Goldstein, V. Rotter, ‘Cancer associated fibroblasts’--more than meets the eye. Trends Mol. Med. 19, 447–453 (2013)CrossRefPubMed S. Madar, I. Goldstein, V. Rotter, ‘Cancer associated fibroblasts’--more than meets the eye. Trends Mol. Med. 19, 447–453 (2013)CrossRefPubMed
6.
Zurück zum Zitat N. Erez, M. Truitt, P. Olson, S.T. Arron, D. Hanahan, Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17, 135–147 (2010)CrossRefPubMed N. Erez, M. Truitt, P. Olson, S.T. Arron, D. Hanahan, Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17, 135–147 (2010)CrossRefPubMed
7.
Zurück zum Zitat P.S. Soon, E. Kim, C.K. Pon, A.J. Gill, K. Moore, A.J. Spillane, D.E. Benn, R.C. Baxter, Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Endocr. Relat. Cancer 20, 1–12 (2013)CrossRefPubMed P.S. Soon, E. Kim, C.K. Pon, A.J. Gill, K. Moore, A.J. Spillane, D.E. Benn, R.C. Baxter, Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells. Endocr. Relat. Cancer 20, 1–12 (2013)CrossRefPubMed
8.
9.
Zurück zum Zitat M. Allen, J. Louise Jones, Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 223, 162–176 (2011)PubMed M. Allen, J. Louise Jones, Jekyll and Hyde: the role of the microenvironment on the progression of cancer. J. Pathol. 223, 162–176 (2011)PubMed
10.
Zurück zum Zitat L. Gonzalez, N. Eiro, B. Fernandez-Garcia, L.O. Gonzalez, F. Dominguez, F.J. Vizoso, Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue. Mol. Carcinog. 55, 1489–1502 (2016) L. Gonzalez, N. Eiro, B. Fernandez-Garcia, L.O. Gonzalez, F. Dominguez, F.J. Vizoso, Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue. Mol. Carcinog. 55, 1489–1502 (2016)
11.
Zurück zum Zitat M.M. Koczorowska, C. Friedemann, K. Geiger, M. Follo, M.L. Biniossek, O. Schilling, Differential effect of TGFbeta on the proteome of cancer associated fibroblasts and cancer epithelial cells in a co-culture approach - a short report. Cell. Oncol. 40, 639–650 (2017)CrossRef M.M. Koczorowska, C. Friedemann, K. Geiger, M. Follo, M.L. Biniossek, O. Schilling, Differential effect of TGFbeta on the proteome of cancer associated fibroblasts and cancer epithelial cells in a co-culture approach - a short report. Cell. Oncol. 40, 639–650 (2017)CrossRef
12.
Zurück zum Zitat N. Eiro, B. Fernandez-Garcia, L.O. Gonzalez, F.J. Vizoso, Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis. Oncoimmunology. 2, e24010 (2013)CrossRefPubMedPubMedCentral N. Eiro, B. Fernandez-Garcia, L.O. Gonzalez, F.J. Vizoso, Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis. Oncoimmunology. 2, e24010 (2013)CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat L.O. Gonzalez, I. Pidal, S. Junquera, M.D. Corte, J. Vazquez, J.C. Rodriguez, M.L. Lamelas, A.M. Merino, J.L. Garcia-Muniz, F.J. Vizoso, Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse. Br. J. Cancer 97, 957–963 (2007)CrossRefPubMedPubMedCentral L.O. Gonzalez, I. Pidal, S. Junquera, M.D. Corte, J. Vazquez, J.C. Rodriguez, M.L. Lamelas, A.M. Merino, J.L. Garcia-Muniz, F.J. Vizoso, Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse. Br. J. Cancer 97, 957–963 (2007)CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat N. Eiro, B. Fernandez-Garcia, J. Vazquez, J.M. Del Casar, L.O. Gonzalez, F.J. Vizoso, A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer. Oncoimmunology 4, e992222 (2015)CrossRefPubMedPubMedCentral N. Eiro, B. Fernandez-Garcia, J. Vazquez, J.M. Del Casar, L.O. Gonzalez, F.J. Vizoso, A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer. Oncoimmunology 4, e992222 (2015)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat L.O. Gonzalez, S. Gonzalez-Reyes, L. Marin, L. Gonzalez, J.M. Gonzalez, M.L. Lamelas, A.M. Merino, E. Rodriguez, I. Pidal, J.M. del Casar, A. Andicoechea, F. Vizoso, Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas. Histopathology 57, 862–876 (2010)CrossRefPubMed L.O. Gonzalez, S. Gonzalez-Reyes, L. Marin, L. Gonzalez, J.M. Gonzalez, M.L. Lamelas, A.M. Merino, E. Rodriguez, I. Pidal, J.M. del Casar, A. Andicoechea, F. Vizoso, Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumour stromal mononuclear inflammatory cells and those at the invasive front of breast carcinomas. Histopathology 57, 862–876 (2010)CrossRefPubMed
16.
Zurück zum Zitat B. Fernandez-Garcia, N. Eiro, M.A. Miranda, S. Cid, L.O. Gonzalez, F. Dominguez, F.J. Vizoso, Prognostic significance of inflammatory factors expression by stroma from breast carcinomas. Carcinogenesis 37, 768–776 (2016)CrossRefPubMed B. Fernandez-Garcia, N. Eiro, M.A. Miranda, S. Cid, L.O. Gonzalez, F. Dominguez, F.J. Vizoso, Prognostic significance of inflammatory factors expression by stroma from breast carcinomas. Carcinogenesis 37, 768–776 (2016)CrossRefPubMed
17.
Zurück zum Zitat E. Zudaire, L. Gambardella, C. Kurcz, S. Vermeren, A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385 (2011)CrossRefPubMedPubMedCentral E. Zudaire, L. Gambardella, C. Kurcz, S. Vermeren, A computational tool for quantitative analysis of vascular networks. PLoS One 6, e27385 (2011)CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat M.A. Taylor, Y.H. Lee, W.P. Schiemann, Role of TGF-beta and the tumor microenvironment during mammary tumorigenesis. Gene Expr. 15, 117–132 (2011)CrossRefPubMed M.A. Taylor, Y.H. Lee, W.P. Schiemann, Role of TGF-beta and the tumor microenvironment during mammary tumorigenesis. Gene Expr. 15, 117–132 (2011)CrossRefPubMed
19.
Zurück zum Zitat B. Bierie, H.L. Moses, Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506–520 (2006)CrossRefPubMed B. Bierie, H.L. Moses, Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat. Rev. Cancer 6, 506–520 (2006)CrossRefPubMed
20.
Zurück zum Zitat A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, R.A. Weinberg, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005)CrossRefPubMed A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, R. Naeem, V.J. Carey, A.L. Richardson, R.A. Weinberg, Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 121, 335–348 (2005)CrossRefPubMed
21.
Zurück zum Zitat A.W. Studebaker, G. Storci, J.L. Werbeck, P. Sansone, A.K. Sasser, S. Tavolari, T. Huang, M.W. Chan, F.C. Marini, T.J. Rosol, M. Bonafe, B.M. Hall, Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 68, 9087–9095 (2008)CrossRefPubMed A.W. Studebaker, G. Storci, J.L. Werbeck, P. Sansone, A.K. Sasser, S. Tavolari, T. Huang, M.W. Chan, F.C. Marini, T.J. Rosol, M. Bonafe, B.M. Hall, Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 68, 9087–9095 (2008)CrossRefPubMed
22.
Zurück zum Zitat J.M. Wang, X. Deng, W. Gong, S. Su, Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods 220, 1–17 (1998)CrossRefPubMed J.M. Wang, X. Deng, W. Gong, S. Su, Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods 220, 1–17 (1998)CrossRefPubMed
23.
Zurück zum Zitat D.E. Hu, Y. Hori, T.P. Fan, Interleukin-8 stimulates angiogenesis in rats. Inflammation 17, 135–143 (1993)CrossRefPubMed D.E. Hu, Y. Hori, T.P. Fan, Interleukin-8 stimulates angiogenesis in rats. Inflammation 17, 135–143 (1993)CrossRefPubMed
24.
Zurück zum Zitat T. Bachelot, I. Ray-Coquard, C. Menetrier-Caux, M. Rastkha, A. Duc, J.Y. Blay, Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br. J. Cancer 88, 1721–1726 (2003)CrossRefPubMedPubMedCentral T. Bachelot, I. Ray-Coquard, C. Menetrier-Caux, M. Rastkha, A. Duc, J.Y. Blay, Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br. J. Cancer 88, 1721–1726 (2003)CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat R. Salgado, S. Junius, I. Benoy, P. Van Dam, P. Vermeulen, E. Van Marck, P. Huget, L.Y. Dirix, Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int. J. Cancer 103, 642–646 (2003)CrossRefPubMed R. Salgado, S. Junius, I. Benoy, P. Van Dam, P. Vermeulen, E. Van Marck, P. Huget, L.Y. Dirix, Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int. J. Cancer 103, 642–646 (2003)CrossRefPubMed
26.
Zurück zum Zitat I.H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P.B. Vermeulen, L.Y. Dirix, Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin. Cancer Res. 10, 7157–7162 (2004)CrossRefPubMed I.H. Benoy, R. Salgado, P. Van Dam, K. Geboers, E. Van Marck, S. Scharpe, P.B. Vermeulen, L.Y. Dirix, Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival. Clin. Cancer Res. 10, 7157–7162 (2004)CrossRefPubMed
27.
Zurück zum Zitat Y. Cao, Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis. Trends Mol. Med. 19, 460–473 (2013)CrossRefPubMed Y. Cao, Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis. Trends Mol. Med. 19, 460–473 (2013)CrossRefPubMed
28.
Zurück zum Zitat M. Jechlinger, A. Sommer, R. Moriggl, P. Seither, N. Kraut, P. Capodiecci, M. Donovan, C. Cordon-Cardo, H. Beug, S. Grunert, Autocrine PDGFR signaling promotes mammary cancer metastasis. J. Clin. Invest. 116, 1561–1570 (2006)CrossRefPubMedPubMedCentral M. Jechlinger, A. Sommer, R. Moriggl, P. Seither, N. Kraut, P. Capodiecci, M. Donovan, C. Cordon-Cardo, H. Beug, S. Grunert, Autocrine PDGFR signaling promotes mammary cancer metastasis. J. Clin. Invest. 116, 1561–1570 (2006)CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat M.M. Mueller, N.E. Fusenig, Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839–849 (2004)CrossRefPubMed M.M. Mueller, N.E. Fusenig, Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4, 839–849 (2004)CrossRefPubMed
30.
Zurück zum Zitat D. Engelmann, D. Mayoli-Nussle, C. Mayrhofer, K. Furst, V. Alla, A. Stoll, A. Spitschak, K. Abshagen, B. Vollmar, S. Ran, B.M. Putzer, E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B. J. Mol. Cell Biol. 5, 391–403 (2013)CrossRefPubMedPubMedCentral D. Engelmann, D. Mayoli-Nussle, C. Mayrhofer, K. Furst, V. Alla, A. Stoll, A. Spitschak, K. Abshagen, B. Vollmar, S. Ran, B.M. Putzer, E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B. J. Mol. Cell Biol. 5, 391–403 (2013)CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat P. Manders, L.V. Beex, V.C. Tjan-Heijnen, J. Geurts-Moespot, T.H. Van Tienoven, J.A. Foekens, C.G. Sweep, The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy. Br. J. Cancer 87, 772–778 (2002)CrossRefPubMedPubMedCentral P. Manders, L.V. Beex, V.C. Tjan-Heijnen, J. Geurts-Moespot, T.H. Van Tienoven, J.A. Foekens, C.G. Sweep, The prognostic value of vascular endothelial growth factor in 574 node-negative breast cancer patients who did not receive adjuvant systemic therapy. Br. J. Cancer 87, 772–778 (2002)CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat H. Bando, H.A. Weich, M. Brokelmann, S. Horiguchi, N. Funata, T. Ogawa, M. Toi, Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br. J. Cancer 92, 553–561 (2005)CrossRefPubMedPubMedCentral H. Bando, H.A. Weich, M. Brokelmann, S. Horiguchi, N. Funata, T. Ogawa, M. Toi, Association between intratumoral free and total VEGF, soluble VEGFR-1, VEGFR-2 and prognosis in breast cancer. Br. J. Cancer 92, 553–561 (2005)CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat S. Ghosh, C.A. Sullivan, M.P. Zerkowski, A.M. Molinaro, D.L. Rimm, R.L. Camp, G.G. Chung, High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer. Hum. Pathol. 39, 1835–1843 (2008)CrossRefPubMedPubMedCentral S. Ghosh, C.A. Sullivan, M.P. Zerkowski, A.M. Molinaro, D.L. Rimm, R.L. Camp, G.G. Chung, High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer. Hum. Pathol. 39, 1835–1843 (2008)CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat S.O. Wurtz, A.S. Schrohl, N.M. Sorensen, U. Lademann, I.J. Christensen, H. Mouridsen, N. Brunner, Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr. Relat. Cancer 12, 215–227 (2005)CrossRefPubMed S.O. Wurtz, A.S. Schrohl, N.M. Sorensen, U. Lademann, I.J. Christensen, H. Mouridsen, N. Brunner, Tissue inhibitor of metalloproteinases-1 in breast cancer. Endocr. Relat. Cancer 12, 215–227 (2005)CrossRefPubMed
35.
Zurück zum Zitat A. Neri, T. Megha, F. Bettarini, D. Tacchini, M.G. Mastrogiulio, D. Marrelli, E. Pinto, P. Tosi, Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases. Hum. Pathol. 43, 1184–1191 (2012)CrossRefPubMed A. Neri, T. Megha, F. Bettarini, D. Tacchini, M.G. Mastrogiulio, D. Marrelli, E. Pinto, P. Tosi, Is tissue inhibitor of metalloproteinase-1 a new prognosticator for breast cancer? An analysis of 266 cases. Hum. Pathol. 43, 1184–1191 (2012)CrossRefPubMed
36.
Zurück zum Zitat A. Dechaphunkul, M. Phukaoloun, K. Kanjanapradit, K. Graham, S. Ghosh, C. Santos, J.R. Mackey, Prognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer. Int. J. Breast Cancer 2012, 290854 (2012) A. Dechaphunkul, M. Phukaoloun, K. Kanjanapradit, K. Graham, S. Ghosh, C. Santos, J.R. Mackey, Prognostic significance of tissue inhibitor of metalloproteinase-1 in breast cancer. Int. J. Breast Cancer 2012, 290854 (2012)
37.
Zurück zum Zitat N. Eiro, L. Gonzalez, L.O. Gonzalez, B. Fernandez-Garcia, M.L. Lamelas, L. Marin, S. Gonzalez-Reyes, J.M. del Casar, F.J. Vizoso, Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development. PLoS One 7, e49047 (2012)CrossRefPubMedPubMedCentral N. Eiro, L. Gonzalez, L.O. Gonzalez, B. Fernandez-Garcia, M.L. Lamelas, L. Marin, S. Gonzalez-Reyes, J.M. del Casar, F.J. Vizoso, Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development. PLoS One 7, e49047 (2012)CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat N. Eiro, I. Pidal, B. Fernandez-Garcia, S. Junquera, M.L. Lamelas, J.M. del Casar, L.O. Gonzalez, A. Lopez-Muniz, F.J. Vizoso, Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer. PLoS One 7, e52796 (2012)CrossRefPubMedPubMedCentral N. Eiro, I. Pidal, B. Fernandez-Garcia, S. Junquera, M.L. Lamelas, J.M. del Casar, L.O. Gonzalez, A. Lopez-Muniz, F.J. Vizoso, Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer. PLoS One 7, e52796 (2012)CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Y. Lin, R. Huang, L. Chen, S. Li, Q. Shi, C. Jordan, R.P. Huang, Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int. J. Cancer 109, 507–515 (2004)CrossRefPubMed Y. Lin, R. Huang, L. Chen, S. Li, Q. Shi, C. Jordan, R.P. Huang, Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int. J. Cancer 109, 507–515 (2004)CrossRefPubMed
40.
Metadaten
Titel
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis
verfasst von
Noemi Eiro
Lucía González
Anxo Martínez-Ordoñez
Belen Fernandez-Garcia
Luis O. González
Sandra Cid
Francisco Dominguez
Román Perez-Fernandez
Francisco J. Vizoso
Publikationsdatum
01.03.2018
Verlag
Springer Netherlands
Erschienen in
Cellular Oncology / Ausgabe 4/2018
Print ISSN: 2211-3428
Elektronische ISSN: 2211-3436
DOI
https://doi.org/10.1007/s13402-018-0371-y

Weitere Artikel der Ausgabe 4/2018

Cellular Oncology 4/2018 Zur Ausgabe

Neu im Fachgebiet Pathologie